Remove news earnings
article thumbnail

#news #biotech British drug developer Mission Therapeutics plc earns $20m milestone

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: British drug developer Mission Therapeutics plc earns $20m milestone. from European Biotechnology – first and foremost in European biotech [link].

article thumbnail

Health misinformation online abounds

World of DTC Marketing

SUMMARY : In a 2019 Pew Research Center poll, more Americans said they consider made-up news a bigger problem than terrorism, illegal immigration, racism, and sexism. Earning trust is not done through one act or with one product; it’s done through a consistent emphasis on transparency.

Scientist 277
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson

Fierce Pharma

While sales for Johnson & Johnson’s Darzalex continue to boom—as the company reported in its quarterly earnings presentation on Tuesday—the pharma major got more good news about its blockbuster | An appeal arbitrator has rejected Genmab’s claim that it is due additional milestone and royalty payments from Johnson & Johnson for Darzalex.

Sales 81
article thumbnail

Week in Review: Biogen M&A and Layoffs, Earnings Season Heats Up, and 12 Neur.

BioSpace

billion Reata acquisition and layoffs dominated this week’s news, while BMS and Roche reported second-quarter earnings and BioSpace looked at 12 late-stage neuro companies. Biogen’s $7.3

56
article thumbnail

STAT+: Talkspace names a new CEO as its stock price continues to struggle

STAT News

Following a year of executive shakeups and business rejiggering, Talkspace’s third-quarter earnings came with some good news: The company finally appointed a new CEO and key numbers continue to point in the right direction.

98
article thumbnail

Don’t worry, the kids are cool if you cash in on their inheritance

Scienmag

Cash in on the kids’ inheritance and spend up big on the retirement plans – that’s the message coming from the University of South Australia as new research reveals that older people are keen to spend their well-earned savings, rather than passing them on to their kids.

article thumbnail

So much for pharma earning trust back

World of DTC Marketing

Pfizer and Moderna have provided data from their large-scale Phase 3 trials only via news releases , which contained the highly promising news that both vaccines were 90 percent effective or more and have not presented any serious safety concerns. It seems that we were premature to think that pharma is earning trust back.